CRMD
NASDAQ · Pharmaceuticals
Cormedix Inc
$8.70
+0.10 (+1.16%)
Open$8.73
Previous Close$8.60
Day High$8.83
Day Low$8.59
52W High$17.43
52W Low$6.13
Volume—
Avg Volume1.36M
Market Cap680.18M
P/E Ratio3.76
EPS$2.10
SectorPharmaceuticals
Analyst Ratings
Strong Buy
12 analysts
Price Target
+503.4% upside
Current
$8.70
$8.70
Target
$52.50
$52.50
$41.99
$52.50 avg
$66.46
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 302.06M | 151.82M | 142.81M |
| Net Income | 158.01M | 25.07M | 23.58M |
| Profit Margin | 52.3% | 16.5% | 16.5% |
| EBITDA | 146.15M | 47.08M | 40.68M |
| Free Cash Flow | — | 14.58M | 22.25M |
| Rev Growth | +1,545.2% | +9.9% | -6.7% |
| Debt/Equity | 0.36 | 0.10 | 0.09 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,117.26 | +0.92% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $241.00 | +0.80% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $120.60 | +0.84% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.04 | -2.75% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.00 | -0.95% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $78.17 | +1.73% | 12.5 | 33.00B |